We’re thrilled to announce, in accordance with the agreement initially announced on March 2, 2020, that CRYOPDP is now part of Hivest Capital Partners. The independent French Private Equity firm has acquired CRYOPDP’s capital and aims to consolidate the company as a major international player with an extended network and market reach. 

We are proud to announce, CRYOPDP has won an award for "Best Clinical Trial Logistics Provider” by the Asia-Pacific Bioprocessing Excellence Awards. 

This award is given annually to industry leaders and trend-setters in the biopharma scene who demonstrate the highest acknowledgment, superior quality, and service excellence. It is a prestigious honor that serves to recognize the best of the best within our field. 

Following the recent escalation of restrictions in response  to COVID-19 in several countries, we are making every effort to transport our customers shipments to agreed service levels. We are constantly monitoring the evolving situation worldwide and executing our strong contingency plans as necessary.

However, new regulations and limitations set by government authorities and airlines may affect the speed and/or the cost of delivery of shipments at certain times for some destinations.

CRYOPDP is monitoring the evolving situation and is taking every precaution to protect our employees, customers and logistics partners. Our global teams are totally committed to support our customers with mitigation plans across our offices to ensure the best solutions in the regions affected by COVID-19.